CinnaGen, Iran
Chairperson
Haleh Hamedifar, a distinguished pharmaceutical executive, has significantly contributed to the global biopharmaceutical industry. After earning her Pharm.D. from Tehran University of Medical Sciences and an MBA from Linköping University in Sweden, she has led CinnaGen Pharmaceutical Group as CEO and now as chairperson. Under her leadership, CinnaGen evolved from a small diagnostic company into a major biopharmaceutical firm, pioneering biosimilar products and entering international markets. She co-founded several companies, including AryoGen Pharmed and NanoAlvand, CinnaGen ilac driving innovations in biotechnology and pharmaceuticals across the Middle East and beyond. Her strategic initiatives have expanded CinnaGen’s global footprint, making it a key player in exporting high-quality biopharmaceuticals to over 30 countries.